A Randomised Phase IIb Trial of BEvACizumab Added to Temozolomide + IrinOtecan for Children with Refractory/Relapsed Neuroblastoma - BEACON Trial

Project: Research

Participants

Colleges, School and Institutes

Short titleA Randomised Phase IIb Trial of BEvACizumab Added to Temozolomide + IrinOtecan for Children with Refractory/Relapsed Neuroblastoma - BEACON Trial
StatusActive
Effective start/end date1/01/1330/06/21